Inhalopédia | Inhalers

Class
- Long-acting beta-2 agonist (LABA)
Active ingredient
- Formoterol fumarate dihydrate
Device
- Turbuhaler®
Inhalers techniques and maintenance
Age
- 6 +
Typical use
- Asthma
  in addition to an ICS when uncontrolled
Asthma management principles
- COPD (off label)
  initial treatment or in addition to a LAMA when uncontrolled
COPD management principles
Marketed strength
- 6 mcg
- 12 mcg
Number of doses
- 60 doses
Dose indicator
- Yes | Indicator
Usual adult dosage
- 1 inh BID
  Maximum daily dose: 48 mcg
Usual pediatric dosage
- Not recommended as a standalone in pediatrics
Required inspiratory flow
- > 30 - 60 L/min
  Medium-high internal resistance (R4)
Inspiratory flows
Public coverage
- AB – MN – QC | Open/Regular Benefit
  BC – NB – NIHB – NL – NS – ON – PEI – SK – YT | Restricted Benefit with criteria
Provincial coverage criteria
Advantages
- Fast onset of action
Disadvantages
- Risk of misuse without an ICS in asthma (increased mortality)
Side effects

Product monograph

Download

Oxeze®